Bipartisan legislation to cap the cost of insulin at $35 for people with private health insurance advanced through a key Senate committee Wednesday, but its future remains uncertain. The measure cleared the Senate Health, Education, Labor and Pensions Committee by a bipartisan 17-5 vote, with s...
Source: [The Hill](https://thehill.com/policy/healthcare/5984156-senate-committee-advances-insulin-cap-bill/)